Toggle navigation
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
2025 Debates and Didactics in Hematology and Oncology
IASLC WCLC 2025
SOHO 2025
22nd ASBrS Annual Meeting
EHA 2025 Congress
Calendar
View All
Topics
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
Cardio-oncology
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Advertisement
Umbraco.Web.PublishedCache.XmlPublishedCache.XmlPublishedContent
«
1
»
Advertisement
Advertisement
Sep
29
Today In Oncology
Addition of Xevinapant to Platinum-Based Chemoradiotherapy in Unresected Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Modified FOLFIRINOX vs Gemcitabine/Nab-Paclitaxel in Metastatic Pancreatic Cancer
FDA Removes Vandetanib REMS Program
Cancer Deaths Expected to Rise to Over 18 Million in 2050
16 Million PRISM Trial Will Explore AI in Breast Cancer Screening
View More
Advertisement
